SCHEMBL5765567

SCHEMBL5765567

COc1cc(-c2ccc(=O)[nH]n2)ccc1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.76
PDE4B Q07343 3/20 0.76
PDE4C Q08493 3/20 0.76
PDE4D Q08499 3/20 0.76
PDE3B Q13370 4/20 0.64
PDE3A Q14432 4/20 0.64
LMNA P02545 3/20 0.64
MAPK1 P28482 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C9 P11712 2/20 0.64
CYP2C19 P33261 2/20 0.64
TP53 P04637 1/20 0.64
HPGD P15428 1/20 0.64
TSHR P16473 1/20 0.64
BLM P54132 1/20 0.64
PMP22 Q01453 1/20 0.64
APP P05067 1/20 0.58
ALOX12 P18054 2/20 0.56
NFKB1 P19838 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479743 0.86 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL17446992 0.84 PDE4A (0.78) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL11140405 0.81 LMNA (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL12595743 0.81 PDE4A (0.78) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9688064 0.80 LMNA (0.60) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL11005422 0.80 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL11736896 0.79 PDE4A (0.76) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL11626196 0.79 PDE4A (0.76) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10761953 0.79 PDE4B (0.79) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL21969548 0.79 PDE3A (0.70) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037527-A PEEK composite material with biocompatibility and preparation method thereof 安徽赛诺新材料科技有限公司 2026-05-15 CN claimed
CN-122037527-A PEEK composite material with biocompatibility and preparation method thereof 安徽赛诺新材料科技有限公司 2026-05-15 CN disclosed
EP-1611121-A1 PYRIDAZINONE DERIVATIVES AS CDK2-INHIBITORS Aventis Pharma S.A. (FR) 2006-01-04 EP disclosed
WO-2004046130-A1 PYRIDAZINONE DERIVATIVES AS CDK2-INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-06-03 WO disclosed